Tocilizumab 162Mg./0.9Ml Inj. Pfs (Actemra) Tender, Rajasthan - 77288438

NORTH WESTERN RAILWAY has floated a tender for Tocilizumab 162Mg./0.9Ml Inj. Pfs (Actemra). The project location is Ajmer, Rajasthan, India. The reference number is CMSAII2022LP198 and it is closing on 17 Jan 2023. Suppliers can request Register free of cost to get the complete Tender details and download the document.

Expired Tender

Procurement Summary

State : Rajasthan

Summary : Tocilizumab 162Mg./0.9Ml Inj. Pfs (Actemra)

Deadline : 17 Jan 2023

Other Information

Notice Type : Tender

TOT Ref.No.: 77288438

Document Ref. No. : CMSAII2022LP198

Financier : Self Financed

Purchaser Ownership : Public

Document Fees : Refer Document

Tender Value : Refer Document

EMD : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Tocilizumab 162mg./0.9ml Inj. PFS (Actemra)
Contract Type : Goods
Tender Type : PAC - Indigenous
Contract Category : Expenditure
Evaluation Criteria : Itemwise/Consigneewise
Bidding System : Single Packet
Pre-Bid Conference Required : No
Pre-Bid Conference Date Time : Not Applicable
Tendering Section : STORE
Inspection Agency : CONSIGNEE
Publishing Date / Time : 12/01/2023 10:04 Bidding to be Done on IREPS
Procure From Approved Sources : No
Approving Agency : Not Applicable
Closing Date Time : 17/01/2023 14:00
Validity of Offer ( Days) : 60
Ranking Order for Bids : Lowest to Highest
Advertised Value :
Tender Doc. Cost (INR) : 0.00
Earnest Money (INR) : 0.00

Consignee CMSAII Rajasthan 4.00 Numbers

Documents

 Tender Notice

viewNitPdf_4093239.pdf

TENDERCONDITIONSANDINSTRUCTIONS.pdf

IRSConditionsofContract.pdf

1AbbottHealthcarePvt.Ltd_2.pdf

2AbbottIndiaLtd_1.pdf

3ajantapharmalidpdf.pdf

4AkumDurgs_Pharmaceuticals.pdf

6AlkemLtd.pdf

7Allergan.pdf

8AngloFrenchDrugs_IndustriesLtd.pdf

9AristoPharmaceuticals.pdf

10astra.ZenecaPharnaIndiaLtd2.pdf

12balpharmaltd.pdf

13BaxterIndiaPvt.Ltd..pdf

14BaxaltaBioSciencesIndiaPvtLtd.pdf

15BayerZydusPharmaPvt.Ltd.pdf

16BDRPharma.pdf

17BharatBlotechInternationalLtd.pdf

18BharatSerumsandVaccinesLTD1.pdf

19biconltd_1.pdf

21boehringerIngelheimPvtLtd.pdf

22BristolMyserSquibbIndiaPvtLtd.pdf

23cadilahealthcarepdf.pdf

24CadilaPharmLtd.pdf

25CelonLabPvt..pdf

26CentaurPharmPvt.Ltd.pdf

30Coronaremediespvt.ltd.pdf

29ConceptPharmLtd1.pdf

31Denischem.pdf

33EliLilly.pdf

35EISAI.pdf

37ferringpharmpvtltd.pdf

New_Doc_2019-10-07_18.50.14.pdf